BILICKI DANIEL S 4
4 · NANOPHASE TECHNOLOGIES CORPORATION · Filed Nov 21, 2003
Insider Transaction Report
Form 4
BILICKI DANIEL S
VP - Sales & Marketing
Transactions
- Exercise/Conversion
Common Stock
2003-11-20$2.38/sh+21,300$50,588→ 21,300 total - Sale
Common Stock
2003-11-20$5.00/sh−21,300$106,500→ 0 total
Holdings
- 21,000
Stock Option (right to buy)
Exercise: $3.66From: 2004-03-24Exp: 2013-03-24→ Common Stock (21,000 underlying) - 50,000
Stock Option (right to buy)
Exercise: $7.69From: 2001-05-24Exp: 2010-05-24→ Common Stock (50,000 underlying) - 30,000
Stock Option (right to buy)
Exercise: $10.88From: 2002-01-26Exp: 2011-01-26→ Common Stock (30,000 underlying) - 5,000
Common Stock
- 10,000
Stock Option (right to buy)
Exercise: $2.38From: 2000-03-15Exp: 2009-03-15→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Subject to certain restrictions, beginning on this date, options vest in five equal annual installments.
- [F2]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.